title: Changes in levels of peripheral hormones controlling appetite are inconsistent with hyperphagia in leptin-deficient subjects.
abstract: Congenital leptin deficiency, a rare genetic disorder due to a homozygous mutation in the leptin gene (LEP), is accompanied by extreme obesity and hyperphagia. A number of gastrointestinal hormones have been shown to critically regulate food intake but their physiological role in hyperphagic response in congenital leptin deficiency has not been elucidated. This study is the first to evaluate the fasting and postprandial profiles of gut-derived hormones in homozygous and heterozygous carriers of LEP mutation. The study subjects from two consanguineous families consisted of five homozygous and eight heterozygous carriers of LEP mutation, c.398delG. Ten wild-type normal-weight subjects served as controls. Fasting and 1-h postprandial plasma ghrelin, glucagon-like peptide (GLP) 1, peptide YY (PYY), leptin and insulin levels were measured by immunoassays. Fasting plasma ghrelin levels in homozygotes remained remarkably unchanged following food consumption (P = 0.33) in contrast to a significant decline in heterozygous (P < 0.03) and normal (P < 0.02) subjects. A significant postprandial increase in PYY was observed in heterozygous (P < 0.02) and control subjects (P < 0.01), but not in the homozygous group (P = 0.22). A postprandial rise in GLP-1 levels was significant (P < 0.02) in all groups. Interestingly, fasting leptin levels in heterozygotes were not significantly different from controls and did not change significantly following meal. Our results demonstrate that gut hormones play little or no physiological role in driving the hyperphagic response of leptin-deficient subjects. In contrast, fasting and postprandial levels of gut hormones in heterozygous mutation carriers were comparable to those of normal-weight controls.
authors.affiliation: Department of Genomics of Common Disease, Hammersmith Hospital, Imperial College London, Burlington-Danes Building, Du Cane Road, London, W12 0NN, UK.
authors.forename: Sadia
authors.initials: S
authors.lastname: Saeed
authors.forename: Paul R
authors.initials: PR
authors.lastname: Bech
authors.forename: Tayyaba
authors.initials: T
authors.lastname: Hafeez
authors.forename: Rabail
authors.initials: R
authors.lastname: Alam
authors.forename: Mario
authors.initials: M
authors.lastname: Falchi
authors.forename: Mohammad A
authors.initials: MA
authors.lastname: Ghatei
authors.forename: Stephen R
authors.initials: SR
authors.lastname: Bloom
authors.forename: Muhammad
authors.initials: M
authors.lastname: Arslan
authors.forename: Philippe
authors.initials: P
authors.lastname: Froguel
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003241:Consanguinity; D005215:Fasting / Q000097:blood; D005260:Female; D054439:Ghrelin / Q000097:blood*; D052216:Glucagon-Like Peptide 1 / Q000097:blood*; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D006963:Hyperphagia / Q000097:blood* / Q000235:genetics; D007328:Insulin / Q000097:blood*; D020738:Leptin / Q000097:blood / Q000172:deficiency / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D019894:Peptide YY / Q000097:blood*; D019518:Postprandial Period / Q000502:physiology; D055815:Young Adult
chemical_list: D054439:Ghrelin; D007328:Insulin; D020738:Leptin; D019894:Peptide YY; D052216:Glucagon-Like Peptide 1